WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Friday, May 27, 2016

APDA Scientific Advisory Board Deciding 2016-2017 Research Funding


New York, NY, May 26, 2016 

The American Parkinson Disease Association's Scientific Advisory Board (SAB) met this week to review more than 55 grant submissions, all vying for nearly $800,000 in funding that will be awarded to experienced and young scientists in the Parkinson's field.   
APDA is focused on advancing scientific research that supports its mission to Ease the Burden - Find the Cure for Parkinson's disease. 
"The objective of APDA and the SAB is to invest in the best science," commented Dr. David G. Standaert, Chairman of the SAB.  "As we evaluate these proposals we focus on funding researchers who are at the start of their Parkinson's research career. Our aim is to accelerate research and support translational ideas that have the potential to truly improve the quality of life and make a difference."
APDA's SAB is comprised of scientists with a wide array of backgrounds and expertise in all areas relevant to Parkinson's disease (PD) research.  Post-doctoral fellowships are awarded at the $35,000 level to support scientists whose research training holds promise into new insights such as geriatric psychology, pathophysiology, etiology and treatment of PD. Research grants are awarded at $50,000 per year and are available to established junior investigators pursuing research in Parkinson's disease. The prestigious Dr. George C. Cotzias Fellowship is a $240,000 grant given over three years to support promising young physicians and researchers in establishing careers in research, teaching and patient service relevant to the problems, causes, prevention, diagnosis and treatment of Parkinson's disease and related neurological movement disorders.
This critical research funding is possible due to the financial support from APDA's steadfast supporters and the dedicated work of the SAB who gather on a regular basis to diligently review and recommend the most cutting edge research.
This year's meeting was kicked off by Leslie A. Chambers, President & CEO of APDA who recognized four SAB members who reached a twenty year milestone of serving on the board: Marie-Francoise Chesselet, MD, PhD, UCLA David Geffen School of Medicine; Dennis W. Dickson, MD, Mayo Clinic, Jacksonville; Richard Myers, PhD, Boston University School of Medicine; and Mahlon R. DeLong, MD, Emory University School of Medicine
The SAB meeting also included research updates from four of the eight 2015-2016 junior investigators who each represent a vast diversity of research areas that can impact the treatment of PD.   
Vivek K. Unni, MD, PhD, of Oregon Health and Science University is researching how the protein alpha-synuclein forms many types of aggregates that are either potentially toxic or could be protective to cells.  While at Harvard Medical School and Brigham & Women's Hospital in Boston, MA, Tim Bartels, PhD, is working to characterize pathology associated forms of alpha-synuclein to understand more about the mechanism of Parkinson's pathogenesis and quantify their abundance as potential biomarkers.  Jacqueline BurrĂ©, PhD, from Joan & Sanford I. Weill Medical College of Cornell University in New York, has sought to determine the link between age and alpha-synuclein pathology that will facilitate understanding the pathogenesis of sporadic Parkinson's.  Finally, studying non-motor symptoms, perception and cognition as it relates to normal and abnormal brain activity, Alice Cronin-Golomb, PhD, from Boston University, and Joseph DeGutis, PhD, from Boston University and The VA Boston Healthcare System are exploring the effectiveness of exercise and cognitive training interventions in Parkinson's to determine whom it is best suited for.   
The announcement of 2016-2017 grant funding will take place in August.
http://occupational-therapy.advanceweb.com/News/Daily-News-Watch/APDA-Scientific-Advisory-Board-Deciding-2016-2017-Research-Funding.aspx

No comments:

Post a Comment